Subscribe to RSS
DOI: 10.1055/s-2005-871547
Synthesis of Pyrimidine 1′,3′-Anhydro-β-d-psico- and -sorbo-furanosyl Nucleosides
Publication History
Publication Date:
14 June 2005 (online)
![](https://www.thieme-connect.de/media/synlett/200511/lookinside/thumbnails/10.1055-s-2005-871547-1.jpg)
Abstract
A novel approach for the synthesis of pyrimidine 1′,3′-anhydro-β-d-psico- and -sorbo-furanosyl nucleosides 2 and 3, respectively, has been developed. The approach described here employs a readily available O 2,3′-anhydro-β-d-fructofuranosyluracil (1) as a key starting compound.
Key words
pyrimidine nucleosides - hexofuranosides - anhydro derivatives
-
1a
Jepsen JS.Sorensen MD.Wengel J. Oligonucleotides 2004, 14: 130 -
1b
Petersen M.Wengel J. Trends Biotechnol. 2003, 21: 74 -
1c
Imanishi T.Obika S. Chem. Commun. 2002, 1653 -
1d
Leumann CJ. Bioorg. Med. Chem. 2002, 10: 841 - 2
Thibaudeau C.Chattopadhyaya J. Stereoelectronic Effects in Nucleosides and Nucleotides and their Structural Implications Uppsala University Press; Sweden: 1999. jyoti@boc.uu.se; ISBN 91-506-1351-0 -
3a
Pradeepkumar PI.Zamaratski E.Földesi A.Chattopadhyaya J. J. Chem. Soc., Perkin Trans. 2 2001, 402 -
3b
Pradeepkumar PI.Amirkhanov NV.Chattopadhyaya J. Org. Biomol. Chem. 2003, 1: 81 -
3c
Pradeepkumar PI.Cheruku P.Plashkevych O.Acharya P.Gohil S.Chattopadhyaya J. J. Am. Chem. Soc. 2004, 126: 11484 - 4
Roivainen J.Vepsäläinen J.Azhayev A.Mikhailopulo IA. Tetrahedron Lett. 2002, 43: 6553 -
6a
Hrebabecky H.Farkas J.Sorm F. Coll. Czech. Chem. Commun. 1972, 37: 2059 -
6b
Hrebabecky H.Farkas J.Sorm F. Coll. Czech. Chem. Commun. 1974, 39: 1098 - 7
Elliott RD.Niwas S.Riordan JM.Montgomery JA.Secrist JA. Nucleosides Nucleotides 1992, 11: 97 - 8
Sarma MSP.Megati S.Klein RS.Otter BA. Nucleosides Nucleotides 1995, 14: 393 -
9a
Sanchez RA.Orgel LE. J. Mol. Biol. 1970, 47: 531 -
9b
Shannahoff DH.Sanchez RA. J. Org. Chem. 1973, 38: 593 - 10
Holy A. Nucleic Acids Res. 1974, 1: 289 - 11
Codington JF.Doerr IL.Fox JJ. J. Org. Chem. 1964, 29: 564 ; and references therein. - 12
Miah A.Reese CB.Song Q.Sturdy Z.Neidle S.Simpson IJ.Read M.Rayner E. J. Chem. Soc., Perkin Trans. 1 1998, 3277 - 14
Divakar KJ.Reese CB. J. Chem. Soc., Perkin Trans. 1 1982, 1171 - 18
Miles DW.Robins RK.Eyring H. Proc. Natl. Acad. Sci. U.S.A. 1967, 57: 1138 -
19a
Miles DW.Robins MJ.Robins RK.Winkley MW.Eyring H. J. Am. Chem. Soc. 1969, 91: 824 -
19b
Miles DW.Robins MJ.Robins RK.Winkley MW.Eyring H. J. Am. Chem. Soc. 1969, 91: 831 -
19c
Miles DW.Inskeep WH.Robins MJ.Winkley MW.Robins RK.Eyring H. J. Am. Chem. Soc. 1970, 92: 3872 - 20
Yoshimura Y.Ueda T.Matsuda A. Tetrahedron Lett. 1991, 32: 4549
References
Note that the structure of compound 16 in ref. 4 was erroneously described to 1-(1,3-anhydro-β-d-psicofura-nosyl)thymine. Single-crystal X-ray analysis showed that compound 16 actually is methyl 1-deoxy-1-(N 1-thyminyl)-β-d-psicofuranoside: (Roivainen, J.; Reuter, H.; Mikhailopulo, I. A., unpublished). The structures of the anhydro nucleosides 9, 12, and 13 have been proved by X-ray analyses (Roivainen, J. A.; Reuter, H.; Mikhailopulo, I. A., unpublished).
13The 1H NMR and 13C MNR data for the psicoside 3 are in agreement with those previously published. [3b]
151-(1,3-Anhydro-β-d-psicofuranosyl)uracil (2): amorphous powder; UV (MeOH): λmax = 257 nm (ε 9500), λmin = 227 (ε 2700) nm. 1H NMR (500.13 MHz, DMSO-d 6): δTMS = 7.44 (d, 1 H, J 5,6 = 7.99 Hz, H6), 5.63 (d, 1 H, H5), 5.25 (d, 1 H, J 3 ′ ,4 ′ = 3.91 Hz, H3′), 5.21 (br s, 1 H, 4′-OH), 5.00 (d, 1 H, J 1 ′ ,1 ′′ = 8.13 Hz, H1′), 4.82 (br t, 1 H, J = 4.10 Hz, 6′-OH), 4.57 (d, 1 H, H1′′), 4.07 (ddd, 1 H, J 4 ′ ,5 ′ = 8.59 Hz, J 5 ′ ,6 ′ = 2.0 Hz, J 5 ′ ,6 ′′ = 5.68 Hz, H5′), 4.03 (br m, 1 H, H4′), 3.75 (br d, 1 H, J 6 ′ ,6 ′′ = 12.9 Hz, H6′), 3.50 (br m, 1 H, H6′′) ppm. 13C NMR (125.77 MHz, DMSO-d 6): δTMS = 163.22 (C4), 149.24 (C2), 141.60 (C6), 101.96 (C5), 90.85 (C2′), 86.84 (C3′), 83.30 (C5′), 77.83 (C1′), 69.65 (C4′), 60.57 (C6′) ppm. Anal. Calcd for C10H12N2O6: C, 46.88; H, 4.72; N, 10.93. Found: C, 46.77; H, 4.63; N, 10.90.
161-(1,3-Anhydro-β-d-sorbofuranosyl)uracil (4): amorphous powder; UV (MeOH): λmax = 256 nm (ε 9900), λmin = 227 nm (ε 2800). 1H NMR (500.13 MHz, (DMSO-d 6): δTMS = 11.39 (br s, 1 H, N 3H), 7.40 (d, 1 H, J 5,6 = 8.05 Hz, H6), 5.73 (d, 1 H, H5), 5.60 (d, 1 H, J = 4.42 Hz, 4′-OH), 5.17 (s, 1 H, J 3 ′ ,4 ′ < 0.5 Hz, H3′), 5.04 (d, 1 H, J 1 ′ ,1 ′′ = 8.28 Hz, H1′), 4.80 (t, 1 H, J = 5.70 Hz, 6′-OH), 4.57 (d, 1 H, H1′′), 4.42 (m, 1 H, J 4 ′ ,5 ′ = 3.35 Hz, J 5 ′ ,6 ′ = 5.54 Hz, J 5 ′ ,6 ′′ = 5.88 Hz, H5′), 4.10 (br t, 1 H, H4′), 3.74 (ddd, 1 H, J 6 ′ ,6 ′′ = 11.60 Hz, H6′), 3.63 (ddd, 1 H, H6′′) ppm. 13C NMR (125.77 MHz, DMSO-d 6): δTMS = 163.23 (C4), 149.65 (C2), 141.68 (C6), 102.45 (C5), 92.96 (C2′), 91.40 (C3′), 84.92 (C5′), 78.61 (C1′), 70.91 (C4′), 58.79 (C6′). Anal. Calcd for C10H12N2O6: C, 46.88; H, 4.72; N, 10.93. Found: C, 46.75; H, 4.61; N, 10.88.
171-[3,4-Anhydro-1,6-di-O-(4-monomethoxy)-trityl-β-d-psicofuranosyl]uracil (10): amorphous powder; UV (MeOH): λmax = 231.5 nm (ε 26900), λmax = 263 nm (ε 9000), λmin = 225 nm (ε 23500), λmin = 255 nm (ε 8800). 1H NMR (500.13 MHz, DMSO-d 6): δTMS = 11.35 (s, 1 H, N 3H), 7.71 (d, 1 H, J 5,6 = 8.14 Hz, H6), 5.47 (d, 1 H, H5), 4.92 (d, 1 H, J 3 ′ ,4 ′ = 2.54 Hz, H3′), 4.56 (t, 1 H, J 5 ′ ,6 ′ = J 5 ′ ,6 ′′ = 4.26 Hz, H5′), 3.92 (d, 1 H, J 4 ′ ,5 ′ < 0.5 Hz, H4′), 3.61 (d, 1 H, J 1 ′ ,1 ′′ = 9.29 Hz, H1′), 3.16 (d, 1 H, H-1′′), 3.19 (d, H6′ and H6′′) ppm. 13C NMR (125.77 MHz, DMSO-d 6): δTMS = 163.14 (C4), 150.47 (C2), 141.64 (C6), 100.63 (C5), 63.21 (C1′), 95.92 (C2′), 57.37 (C3′), 56.12 (C4′), 79.83 (C5′), 62.65 (C6′) ppm. Anal. Calcd for C50H44N2O8: C, 74.98; H, 5.54; N, 3.50. Found: C, 74.83; H, 5.50; N, 3.42.